Research Paper Volume 5, Issue 3 pp 155—173

Protease-sensitive prions with 144-bp insertion mutations

class="figure-viewer-img"

Figure 5. Determination of both PrPWt and PrPIns in detergent-soluble and -insoluble fractions by Western blotting. A and B: After ultracentrifugation in detergents, PrP in the detergent-soluble fraction (S2) (A) and -insoluble fraction (P2) (B) was detected by Western blotting with the anti-PrP antibody anti-N detecting the full-length PrP. Lane1: non-CJD control; Lane 2 fCJDIns+sPrPSc (case 6); Lanes 3 to 7: fCJDIns+rPrPSc (cases 1-5); Lane 8: sCJD control. C: Comparing compositions of total PrP, PrPIns, and PrPWt in fCJDIns+sPrPSc (case 6) and fCJDIns+rPrPSc (cases 1-5, mean) by densitometric analysis of PrP intensity detected with Western blotting as shown in A and B. The left four bars exhibit the percentage of PrPWt or PrPIns in total PrP including soluble and insoluble forms. The central four bars exhibit the percentage of soluble or insoluble form in total PrPIns. The right four bars exhibit the percentage of soluble or insoluble form in total PrPWt. There were no significant differences in the percentage of PrPWt or PrPIns in total PrP between fCJDIns+sPrPSc and fCJDIns+rPrPSc (62.5/37.5 vs 63.4/36.6). Also there were no significant differences in the percentage of the soluble or insoluble form in PrPIns between the two conditions (36.2/63.8 vs 30.5/69.5). In contrast, the percentage of the soluble form of PrPWt was remarkably greater in fCJDIns+sPrPSc than in fCJDIns+rPrP (54.7% vs 38.4%), while the percentage of the insoluble form of PrPWt was significantly smaller in fCJDIns+sPrPSc than in fCJDIns+rPrPSc (45.3% vs 61.6%). D: Comparison of PrPWt intensity in S2 and P2 fractions between fCJDIns and non-CJD or sCJD. No differences in the levels of PrPWt from soluble or insoluble fraction were detected between fCJDIns and non-CJD or sCJD.